Medi Assist to increase Mayfair We Care stake to 91.75% with Rs 589,270 investment

What Medi Assist announced

Medi Assist Healthcare Services Ltd (BSE: 544088) disclosed that its Board, on 24 June 2026, approved a further cash investment to acquire an additional 31.75% of its UK subsidiary, Mayfair We Care Limited (“Mayfair”). The purchase will raise Medi Assist’s shareholding in Mayfair from 60% to 91.75% of the issued share capital. The acquisition will be executed through a share transfer from existing Mayfair shareholders and is funded with INR equivalent to GBP 589,270.

Details of the acquisition

• Shares and percentage: The company will acquire 1,270 ordinary shares, representing 31.75% of Mayfair’s issued share capital. After the transaction, Medi Assist’s total holding will stand at 91.75%.
• Consideration: The purchase price is cash, amounting to INR equivalent to GBP 589,270 as of the remittance date. The funds will be drawn from the proceeds of a preferential allotment earmarked for general corporate purposes, consistent with shareholder‑approved objects.
• Timing: The acquisition is expected to close by the end of the second quarter of FY 2026‑27, subject to customary closing formalities. No governmental or regulatory approvals are required.
• Leadership changes: Upon completion, Mr. Nikhil Chopra, currently Chief Business Officer of Medi Assist and Director of Mayfair, will become CEO‑designate of Mayfair and assume the CEO role. Mr. Michail Chopra will transition from CEO to Founder & Strategic Advisor.

Mayfair We Care Limited – business snapshot

Mayfair, incorporated on 22 October 2015, operates in the insurance intermediary space, providing health‑claim and health‑benefits administration services to the global health‑insurance market. Financial performance for the year ended 31 March 2026 shows:

• Turnover: INR 410.85 million
• Net profit (after tax): INR 16.31 million The subsidiary is already a part of Medi Assist’s corporate structure, and the transaction is described as arm‑length, with no additional promoter or group interest beyond the existing shareholding.

Key facts at a glance

Why this matters for investors

The acquisition deepens Medi Assist’s control over Mayfair, moving from a majority stake to near‑total ownership. By consolidating leadership under Nikhil Chopra, the group aims to streamline decision‑making and capture synergies in cross‑border health‑administration services. The cash outlay is modest relative to Mayfair’s turnover (≈0.14% of annual revenue) and is financed from a previously approved preferential issue, meaning no immediate dilution to existing shareholders. The arm‑length nature of the deal and the absence of additional regulatory hurdles reduce execution risk. However, investors should note that the transaction will increase exposure to Mayfair’s earnings, which are currently modest (net profit margin ~4%).

Conclusion

Medi Assist’s board has approved a cash investment of INR equivalent to GBP 589,270 to acquire an additional 31.75% of Mayfair We Care, lifting its ownership to 91.75% and appointing a new CEO. The deal is expected to close by the end of Q2 FY 2026‑27, is funded from a preferential allotment, and does not require further regulatory clearance. Completion will give Medi Assist near‑full control of Mayfair’s international health‑claims business, aligning with its long‑term vision of expanding cross‑border health‑administration capabilities.